{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T19:26:42Z","timestamp":1782156402340,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhandsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Hand Surgery"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.jhsa.2008.11.026","type":"journal-article","created":{"date-parts":[[2009,3,2]],"date-time":"2009-03-02T04:09:47Z","timestamp":1235966987000},"page":"446-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Botulinum Toxin Type A: A Treatment Option for Digital Ischemia in Patients With Raynaud's Phenomenon"],"prefix":"10.1016","volume":"34","author":[{"given":"Alero","family":"Fregene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Ditmars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhsa.2008.11.026_bib1","article-title":"Raynaud's phenomenon: a proposal for classification","volume":"10","author":"LeRoy","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jhsa.2008.11.026_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0889-857X(03)00019-X","article-title":"Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma","volume":"29","author":"Hummers","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jhsa.2008.11.026_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.rdc.2005.04.006","article-title":"Raynaud's phenomenon in mixed connective tissue disease","volume":"31","author":"Grader-Beck","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jhsa.2008.11.026_bib4","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8","article-title":"Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis","volume":"44","author":"Thompson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhsa.2008.11.026_bib5","article-title":"Prazosin for Raynaud's phenomenon in progressive systemic sclerosis","author":"Pope","year":"1998","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhsa.2008.11.026_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0363-5023(80)80104-3","article-title":"Digital artery sympathectomy","volume":"5","author":"Flatt","year":"1980","journal-title":"J Hand Surg"},{"key":"10.1016\/j.jhsa.2008.11.026_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0749-0712(21)01362-7","article-title":"Digital sympathectomy for vascular insufficiency","volume":"1","author":"Wilgis","year":"1985","journal-title":"Hand Clin"},{"key":"10.1016\/j.jhsa.2008.11.026_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/micr.1013","article-title":"Surgery for ischemic pain and Raynaud's phenomenon in scleroderma: a description of treatment protocol and evaluation of results","volume":"21","author":"Tomaino","year":"2001","journal-title":"Microsurgery"},{"key":"10.1016\/j.jhsa.2008.11.026_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/rheumatology\/keh390","article-title":"Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis","volume":"44","author":"Thompson","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jhsa.2008.11.026_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2362.2004.01324.x","article-title":"Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study","volume":"34","author":"Sycha","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jhsa.2008.11.026_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.prs.0000244860.00674.57","article-title":"Management of vasospastic disorders with botulinum toxin A","volume":"119","author":"Van Beek","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jhsa.2008.11.026_bib12","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","article-title":"Pain: a review of three commonly used pain rating scales","volume":"14","author":"Williamson","year":"2005","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.jhsa.2008.11.026_bib13","series-title":"Primer of Biostatistics","first-page":"85","year":"1996"},{"key":"10.1016\/j.jhsa.2008.11.026_bib14","doi-asserted-by":"crossref","first-page":"H2124","DOI":"10.1152\/ajpheart.2001.281.5.H2124","article-title":"Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons","volume":"281","author":"Morris","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jhsa.2008.11.026_bib15","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/01.prs.0000287135.17291.2f","article-title":"The effects of botulinum toxin type A on muscle blood perfusion and metabolism","volume":"120","author":"Matic","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jhsa.2008.11.026_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1586\/14737175.7.5.463","article-title":"Botulinum toxin type A in chronic migraine","volume":"7","author":"Freitag","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jhsa.2008.11.026_bib17","article-title":"Botulinum toxin type A therapy for cervical dystonia","author":"Costa","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhsa.2008.11.026_bib18","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","author":"Brin","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jhsa.2008.11.026_bib19","first-page":"47","article-title":"Systemic sclerosis: blood rheometry and laser Doppler imaging of digital cutaneous microcirculation during local cold exposure","volume":"18","author":"Picart","year":"1998","journal-title":"Clin Hemorheol Microcirc"}],"container-title":["The Journal of Hand Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502308010447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502308010447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:52:00Z","timestamp":1759791120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0363502308010447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0363502308010447"],"URL":"https:\/\/doi.org\/10.1016\/j.jhsa.2008.11.026","relation":{},"ISSN":["0363-5023"],"issn-type":[{"value":"0363-5023","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum Toxin Type A: A Treatment Option for Digital Ischemia in Patients With Raynaud's Phenomenon","name":"articletitle","label":"Article Title"},{"value":"The Journal of Hand Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhsa.2008.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}